Judy's Breast Cancer Journey

Judy is a 56-year-old nurse practitioner and 26-year military veteran who was diagnosed with breast cancer in 2003, entered remission for 10 years, but then had a recurrence of her breast cancer in December 2012. JudyÕs cancer progressed despite hormone therapy so her medical oncologist at Tennessee Oncology, Dr. Patrick Murphy, referred her to Sarah Cannon Research Institute in Nashville for a clinical trial.

She was placed on a clinical trial for a drug called abemaciclib, which works to control her cancer by stopping its progression.

Judy has seen great success on the drug, which she has taken for nearly a year. Prior to enrolling on the clinical trial, Judy was prescribed narcotic pain medication to control the pain she felt as a result of her cancer, but now that her condition has improved on the clinical trial, she can continue to work two jobs, care for her family, travel and even started training for a 5k run/walk.

Attending the 13th Pharmacovigilance Meeting in Chicago this week? Don't miss an important discussion with panelist Sheetal Khedkar on CRO/Sponsor communications. September 28th at 11:20am. #VIphv
http://www.virtueinsight.com/pharma/13th-Pharmacovigilance-2017/

Today and tomorrow, Sarah Cannon's physician leaders and experts will be hosting and participating in important discussions at the ASCO Research Community Forum. Dr. Dax Kurbgeov will highlight overcoming challenges with payers for patients on clinical trials & Dr. Skip Burris will discuss the significance of strategic partnerships in cancer research. To learn more about Sarah Cannon's recent acquisition for the advancement of personalized medicine for our patients, read about our collaboration with...